Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06829498
PHASE2

BCAAs in Concussion 2.0

Sponsor: Akiva Cohen

View on ClinicalTrials.gov

Summary

This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.

Official title: HIT HEADS 2.0: Head Injury Treatment: A Randomized, Placebo-controlled, Double-blinded, Therapeutic Clinical Trial of Branched Chain Amino Acids (BCAAs) in the Treatment of Concussion

Key Details

Gender

All

Age Range

11 Years - 23 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-04-01

Completion Date

2026-08

Last Updated

2025-06-13

Healthy Volunteers

No

Interventions

DRUG

BCAA

The three BCAAs will be combined together and dissolved in a flavored solution.

OTHER

Placebo

The placebo solution will have similar taste, texture, consistency and appearance as the BCAA solution.

Locations (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States